Clinical commissioning groups and National Health Service trusts should have due regard to the National Institute for Health and Care Excellence’s guideline ‘Attention deficit hyperactivity disorder: diagnosis and management’. This guideline aims to improve the diagnosis of ADH and the quality of care and support that adults receive, including access to medication. The guideline does not recommend a maximum waiting time for adults to receive ADHD treatment.